Feb 21 - UnitedHealth (UNH, Financial) says the Wall Street Journal's report of a DOJ probe into its Medicare billing practices is misinformation after market jitters triggered an over 9% drop in its shares. The investigation allegedly targets how UnitedHealth records diagnoses to boost Medicare Advantage payments, including at its affiliated physician groups.
Following the WSJ report, UnitedHealth swiftly dismissed the claims, stressing that its Medicare Advantage program undergoes regular government reviews and that no new practices have been introduced. Analysts from RBC Capital Markets view the report as unsubstantiated, suggesting that any probe will likely follow a drawn-out process similar to last year's DOJ anti?trust investigation.
This article first appeared on GuruFocus.免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。